In our prior genetic analysis of the UK Biobank, we refined a heterogeneous heart failure phenotype to a specific, nonischemic cardiomyopathy subset, enabling detection of two DCM risk loci (near BAG3 and CLCNKA) that associated with subclinical changes in LV structure and function32. This evidence concerns the gene CLCNKA and heart failure.